相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma
A. Scherpereel et al.
EUROPEAN RESPIRATORY JOURNAL (2010)
Evaluation of an Attenuated Vesicular Stomatitis Virus Vector Expressing Interferon-beta for Use in Malignant Pleural Mesothelioma: Heterogeneity in Interferon Responsiveness Defines Potential Efficacy
Vassiliki Saloura et al.
HUMAN GENE THERAPY (2010)
SV40-Induced Expression of Calretinin Protects Mesothelial Cells from Asbestos Cytotoxicity and May Be a Key Factor Contributing to Mesothelioma Pathogenesis
Thomas Henzi et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
Clinical Impact and Reliability of Pleural Fluid Mesothelin in Undiagnosed Pleural Effusions
Helen E. Davies et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2009)
Immunogenic cell death modalities and their impact on cancer treatment
Oliver Kepp et al.
APOPTOSIS (2009)
Tumorigenic properties of alternative osteopontin isoforms in mesothelioma
Sergey V. Ivanov et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
Combination of active specific immunotherapy or adoptive antibody or lymphocyte immunotherapy with chemotherapy in the treatment of cancer
Tianqian Zhang et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2009)
Expression of IFN-β Enhances Both Efficacy and Safety of Oncolytic Vesicular Stomatitis Virus for Therapy of Mesothelioma
Candice L. Willmon et al.
CANCER RESEARCH (2009)
Serum mesothelin has a higher diagnostic utility than hyaluronic acid in malignant mesothelioma
Bogdan Grigoriu et al.
CLINICAL BIOCHEMISTRY (2009)
Phase I Trial of Continuous Infusion Anti-Mesothelin Recombinant Immunotoxin SS1P
Robert J. Kreitman et al.
CLINICAL CANCER RESEARCH (2009)
Adoptive cell therapy for the treatment of patients with metastatic melanoma
Steven A. Rosenberg et al.
CURRENT OPINION IN IMMUNOLOGY (2009)
Improving the outcome in malignant pleural mesothelioma: nonaggressive or aggressive approach?
Rolf A. Stahel et al.
CURRENT OPINION IN ONCOLOGY (2009)
New frontiers in cell-based immunotherapy of cancer
Mario Milco D'Elios et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2009)
Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation
G. Solinas et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2009)
Chemoimmunotherapy: an emerging strategy for the treatment of malignant mesothelioma
M. J. McCoy et al.
TISSUE ANTIGENS (2009)
Immunogenic and tolerogenic cell death
Douglas R. Green et al.
NATURE REVIEWS IMMUNOLOGY (2009)
Soluble mesothelin-related protein in an asbestos-exposed population - The dust diseases board cohort study
Eun-Kee Park et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2008)
Combined modality immunotherapy and chemotherapy: a new perspective
Rupal Ramakrishnan et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2008)
Measles virus induces oncolysis of mesothelioma cells and allows dendritic cells to cross-prime tumor-specific CD8 response
Anne Gauvrit et al.
CANCER RESEARCH (2008)
Dendritic cell-based cancer vaccination:: quo vadis?
M. Dauer et al.
EXPERT REVIEW OF VACCINES (2008)
Toll-like receptors, transduction-effector pathways, and disease diversity: Evidence of an immunobiological paradigm explaining all human illness?
Timothy J. Atkinson
INTERNATIONAL REVIEWS OF IMMUNOLOGY (2008)
Dendritic Cells: A Critical Player in Cancer Therapy?
Anna Karolina Palucka et al.
JOURNAL OF IMMUNOTHERAPY (2008)
Comparison of osteopontin, megakaryocyte potentiating factor, and mesothelin proteins as markers in the serum of patients with malignant mesothelioma
Jenette Creaney et al.
JOURNAL OF THORACIC ONCOLOGY (2008)
Early-life pulmonary arterial hypertension with subsequent development of diffuse pulmonary arteriovenous malformations in hereditary haemorrhagic telangiectasia type 1
C. J. Mache et al.
THORAX (2008)
Tumor stress, cell death and the ensuing immune response
E. Ullrich et al.
CELL DEATH AND DIFFERENTIATION (2008)
Molecular characteristics of immunogenic cancer cell death
A. Tesniere et al.
CELL DEATH AND DIFFERENTIATION (2008)
The interaction between HMGB1 and TLR4 dictates the outcome of anticancer chemotherapy and radiotherapy
Lionel Apetoh et al.
IMMUNOLOGICAL REVIEWS (2007)
Phase I study of SS1P a recombinant anti-mesothelin immunotoxin given as a bolus IV infusion to patients with mesothelin-expressing mesothelioma, ovarian, and pancreatic cancers
Raffit Hassan et al.
CLINICAL CANCER RESEARCH (2007)
A phase I clinical trial of single-dose intrapleural IFN-β gene transfer for malignant pleural mesothelioma and metastatic pleural effusions:: High rate of antitumor immune responses
Daniel H. Sterman et al.
CLINICAL CANCER RESEARCH (2007)
Utility of osteopontin and serum mesothelin in malignant pleural mesothelioma diagnosis and prognosis assessment
Bogdan-Dragos Grigoriu et al.
CLINICAL CANCER RESEARCH (2007)
Systemic efficacy with oncolytic virus therapeutics: Clinical proof-of-concept and future directions
Ta-Chiang Liu et al.
CANCER RESEARCH (2007)
Calreticulin exposure dictates the immunogenicity of cancer cell death
Michel Obeid et al.
NATURE MEDICINE (2007)
The role of SV40 in malignant mesothelioma and other human malignancies
Mark A. Pershouse et al.
INHALATION TOXICOLOGY (2006)
Gene therapy for malignant mesothelioma: beyond the infant years
R. G. van der Most et al.
CANCER GENE THERAPY (2006)
Tumor-directed radiation and the immunotoxin SS1P in the treatment of mesothelin-expressing tumor xenografts
Raffit Hassan et al.
CLINICAL CANCER RESEARCH (2006)
Mesothelioma environment comprises cytokines and T-regulatory cells that suppress immune responses
J. P. J. J. Hegmans et al.
EUROPEAN RESPIRATORY JOURNAL (2006)
Soluble mesothelin-related peptides in the diagnosis of malignant pleural mesothelioma
Arnaud Scherpereel et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2006)
Recombinant GM-CSF plus autologous tumor cells as a vaccine for patients with mesothelioma
A Powell et al.
LUNG CANCER (2006)
Imaging and therapy of malignant pleural mesothelioma using replication-competent herpes simplex viruses
Prasad S. Adusumilli et al.
JOURNAL OF GENE MEDICINE (2006)
IL-2 administration increases CD4+CD25hi Foxp3+ regulatory T cells in cancer patients
M Ahmadzadeh et al.
BLOOD (2006)
Evolving aspects of mesothelioma carcinogenesis: SV40 and genetic predisposition
Michele Carbone et al.
JOURNAL OF THORACIC ONCOLOGY (2006)
Detection and quantitation of serum mesothelin, a tumor marker for patients with mesothelioma and ovarian cancer
R Hassan et al.
CLINICAL CANCER RESEARCH (2006)
Foxp3 expressing CD4(+) CD25(+) and CD8(+)CD28(-) T regulatory cells in the peripheral blood of patients with lung cancer and pleural mesothelioma
Federica Meloni et al.
HUMAN IMMUNOLOGY (2006)
Cisplatin-induced GADD34 upregulation potentiates oncolytic viral therapy in the treatment of malignant pleural mesothelioma
PS Adusumilli et al.
CANCER BIOLOGY & THERAPY (2006)
The French National Mesothelioma Surveillance Program
M. Goldberg et al.
OCCUPATIONAL AND ENVIRONMENTAL MEDICINE (2006)
Recent progress in the battle between oncolytic viruses and tumours
KA Parato et al.
NATURE REVIEWS CANCER (2005)
Enhancement of vaccine-mediated antitumor immunity in cancer patients after depletion of regulatory T cells
J Dannull et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Long-term follow-up of patients with malignant pleural mesothelioma receiving high-dose adenovirus herpes simplex thymidine kinase/ganciclovir suicide gene therapy
DH Sterman et al.
CLINICAL CANCER RESEARCH (2005)
Asbestos exposure, pleural mesothelioma, and serum osteopontin levels
HI Pass et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Leveraging the activity of tumor vaccines with cytotoxic chemotherapy
LA Emens et al.
CANCER RESEARCH (2005)
Humoral immune response to mesothelin in mesothelioma and ovarian cancer patients
M Ho et al.
CLINICAL CANCER RESEARCH (2005)
Opinion - Immunotherapy and chemotherapy - a practical partnership
RA Lake et al.
NATURE REVIEWS CANCER (2005)
Measles as a potential oncolytic virus
AK Fielding
REVIEWS IN MEDICAL VIROLOGY (2005)
Regulatory T cells and cytokines in malignant pleural effusions secondary to mesothelioma and carcinoma
P DeLong et al.
CANCER BIOLOGY & THERAPY (2005)
Differentiation and expression of T cells with regulatory function from human peripheral lymphocytes by stimulation in the presence of TGF-β
PE Rao et al.
JOURNAL OF IMMUNOLOGY (2005)
Characterization of effusion-infiltrating T cells:: Benign versus malignant effusions
D Atanackovic et al.
CLINICAL CANCER RESEARCH (2004)
Mesothelin: A new target for immunotherapy
R Hassan et al.
CLINICAL CANCER RESEARCH (2004)
Cancer regression in patients with metastatic melanoma after the transfer of autologous antitumor lymphocytes
SA Rosenberg et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Mesothelin-family proteins and diagnosis of mesothelioma
BWS Robinson et al.
LANCET (2003)
A molecularly cloned Schwarz strain of measles virus vaccine induces strong immune responses in Macaques and transgenic mice
C Combredet et al.
JOURNAL OF VIROLOGY (2003)
Efficacy of CD40 ligand gene therapy in malignant mesothelioma
PL Friedlander et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2003)
Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma
NJ Vogelzang et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Anti-cancer therapy using dendritic cells and apoptotic tumour cells:: pre-clinical data in human mesothelioma and acute myeloid leukaemia
M Grégoire et al.
VACCINE (2003)
Therapeutic efficacy of melanoma-reactive TIL injected in stage III melanoma patients
N Labarrière et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2002)
Cancer testis antigens expression in mesothelioma: role of DNA methylation and bioimmunotherapeutic implications
L Sigalotti et al.
BRITISH JOURNAL OF CANCER (2002)
The immune anti-tumor effects of GM-CSF and B7-1 gene transfection are enhanced by surgical debulking of tumor
S Mukherjee et al.
CANCER GENE THERAPY (2001)
A role for TGF-β in the generation and expansion of CD4+CD25+ regulatory T cells from human peripheral blood
S Yamagiwa et al.
JOURNAL OF IMMUNOLOGY (2001)
Localised spontaneous regression in mesothelioma - possible immunological mechanism
BWS Robinson et al.
LUNG CANCER (2001)
Serologic responses in patients with malignant mesothelioma - Evidence for both public and private specificities
C Robinson et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2000)
分享论文
